Guidelines for acromegaly management

被引：248

作者：

Melmed, S

Casanueva, FF

Cavagnini, F

Chanson, P

Frohman, L

Grossman, A

Ho, K

Kleinberg, D

Lamberts, S

Laws, E

Lombardi, G

Vance, ML

Von Werder, K

Wass, J

Giustina, A

机构：

[1] Univ Calif Los Angeles, Sch Med, Cedars Sinai Res Inst, Los Angeles, CA 90048 USA

[2] Univ Santiago de Compostela, Santiago De Compostela, Spain

[3] Univ Milan, Milan, Italy

[4] Hop Bicetre, Le Kremlin Bicetre, France

[5] Univ Illinois, Chicago, IL USA

[6] St Bartholomews Hosp, London, England

[7] Garvan Inst Med Res, Sydney, NSW, Australia

[8] NYU Med Ctr, New York, NY 10016 USA

[9] Univ Rotterdam Hosp, Rotterdam, Netherlands

[10] Univ Virginia, Charlottesville, VA USA

[11] Sch Med, Naples, Italy

[12] Schlosspk Klin, Berlin, Germany

[13] Radcliffe Infirm, Oxford OX2 6HE, England

[14] Univ Brescia, Brescia, Italy

来源：

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2002年 / 87卷 / 09期

关键词：

D O I：

10.1210/jc.2002-011841

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：4054 / 4058

页数：5

共 41 条

[1] Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: Initial outcome and long-term results [J].

Abosch, A ;

Tyrrell, JB ;

Lamborn, KR ;

Hannegan, LT ;

Applebury, CB ;

Wilson, CB .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (10) :3411-3418

[2] Cabergoline in the treatment of acromegaly: A study in 64 patients [J].

Abs, R ;

Verhelst, J ;

Maiter, D ;

Van Acker, K ;

Nobels, F ;

Coolens, JL ;

Mahler, C ;

Beckers, A .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (02) :374-378

[3] Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly [J].

Barkan, AL ;

Halasz, I ;

Dornfeld, KJ ;

Jaffe, CA ;

Friberg, RD ;

Chandler, WF ;

Sandler, HM .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (10) :3187-3191

[4]

BATES AS, 1993, Q J MED, V86, P293

[5] RISK OF 2ND BRAIN-TUMOR AFTER CONSERVATIVE SURGERY AND RADIOTHERAPY FOR PITUITARY-ADENOMA [J].

BRADA, M ;

FORD, D ;

ASHLEY, S ;

BLISS, JM ;

CROWLEY, S ;

MASON, M ;

RAJAN, B ;

TRAISH, D .

BRITISH MEDICAL JOURNAL, 1992, 304 (6838) :1343-1346

[6] Three year follow-up of acromegalic patients treated with intramuscular slow-release lanreotide [J].

Caron, P ;

MorangeRamos, I ;

Cogne, M ;

Jaquet, P .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (01) :18-22

[7] Predicting the effects of long-term medical treatment in acromegaly. At what cost? For what benefits? [J].

Chanson, P .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1997, 136 (04) :359-361

[8] Complications of transsphenoidal surgery: Results of a national survey, review of the literature, and personal experience [J].

Ciric, I ;

Ragin, A ;

Baumgartner, C ;

Pierce, D .

NEUROSURGERY, 1997, 40 (02) :225-236

[9] Effect of octreotide pretreatment on surgical outcome in acromegaly [J].

Colao, A ;

Ferone, D ;

Cappabianca, P ;

DeCaro, MLD ;

Marzullo, P ;

Monticelli, A ;

Alfieri, A ;

Merola, B ;

Cali, A ;

deDivitiis, E ;

Lombardi, G .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (10) :3308-3314

[10] RESULTS OF SURGICAL-TREATMENT FOR GROWTH HORMONE-SECRETING PITUITARY-ADENOMAS [J].

DAVIS, DH ;

LAWS, ER ;

ILSTRUP, DM ;

SPEED, JK ;

CARUSO, M ;

SHAW, EG ;

ABBOUD, CF ;

SCHEITHAUER, BW ;

ROOT, LM ;

SCHLECK, C .

JOURNAL OF NEUROSURGERY, 1993, 79 (01) :70-75

← 1 2 3 4 5 →